Share on StockTwits

Research analysts at Wedbush initiated coverage on shares of Intersect ENT (NASDAQ:XENT) in a report released on Monday. The firm set an “outperform” rating on the stock.

Shares of Intersect ENT (NASDAQ:XENT) opened at 15.05 on Monday. Intersect ENT has a 52 week low of $12.02 and a 52 week high of $15.77. The stock has a 50-day moving average of $13.24 and a 200-day moving average of $13.24. The company’s market cap is $338.6 million.

Several other analysts have also recently commented on the stock. Analysts at JPMorgan Chase & Co. initiated coverage on shares of Intersect ENT in a research note on Monday. They set an “overweight” rating and a $22.00 price target on the stock. Separately, analysts at Leerink Swann initiated coverage on shares of Intersect ENT in a research note on Monday. They set an “outperform” rating and a $20.00 price target on the stock. Finally, analysts at Piper Jaffray initiated coverage on shares of Intersect ENT in a research note on Monday. They set an “overweight” rating and a $20.00 price target on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.